169158 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
Metabolically competent cells, methods of making, and uses thereof
#302Non-radioactive cytotoxicity assays
#303ISOLATED INTESTINAL MUCOSA AND USES THEREOF
#304Treatment methods having reduced drug-related toxicity and methods of identifying the likelihood of patient harm from prescribed medications
#305Methods for improving cell viability in a production bioreactor
#306Multi-component in vitro system to deduce cell signaling pathways by electronic stimulation patterns
#307Encapsulated liver tissue
#308Flatbed air-liquid interface exposure module and methods
#309In vitro nephrotoxicity screening assay
#310METHODS AND SYSTEMS FOR SCREENING CANDIDATE COMPOUNDS FOR THEIR POTENTIAL TO CAUSE SYSTEMIC OR HEPATIC TOXICITY
#311ASSAY AND METHOD FOR DETERMINING CDC ELICITING ANTIBODIES
#312Methods for screening cereblon modifying compounds
#313METHODS TO GENERATE POLYMER SCAFFOLDS HAVING A GRADIENT OF CROSSLINKING DENSITY
#314Molecule sensor systems
#315CELL-FREE SENSOR SYSTEMS
#316Method of measuring cell-substrate impedance in living cells to identify compounds affecting receptor tyrosine kinase (RTK) activity and pathways for the treatment of cancer
#317Integrated microfluidic system for culturing and testing
#318Methods of Treating Cancers With Chemotherapy With Reduced Toxicity
#319SYSTEMS AND METHODS FOR MODELING DISEASE AND ASSESSING ADVERSE SIDE EFFECTS OF THERAPEUTICS THEREFOR
#320Method for manufacturing ciliary marginal zone-like structure
#321METHODS FOR DETERMINING THE EFFICACY PROFILE OF A DRUG CANDIDATE
#322Methods of treating and preventing infections and associated conditions
#323PREDICTING HUMAN DEVELOPMENTAL TOXICITY OF PHARMACEUTICALS USING HUMAN STEM-LIKE CELLS AND METABOLOMIC RATIOS
#324Method for producing retinal tissue
#325Cell culture
#326INDICATOR STEM CELL LINE/LIVING ORGANISM (NON-HUMAN) AND A METHOD FOR DETECTION OF THE GENOTOXIC POTENTIAL OF AQUATIC SAMPLES OR AQUEOUS SOLUTIONS OF TEST COMPOUNDS
#327Efficient generation of human red blood cells via enriching peripheral blood erythroid progenitors
#328METHOD AND SYSTEM FOR CONTINUOUS BIOSENSING
#3293-D TISSUE CULTURE BASED METHOD TO ASSESS MITOCHONDRIAL IMPAIRMENT
#330Derivation of human microglia from pluripotent stem cells
#331Intermittent starvation techniques to prolong functional lifetime of liver cells in culture
#332In vitro assays for inhibition of microglial activation
#333Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations
#334Use of Neuropilin-1 (NRP1) as a cell surface marker for isolating human cardiac ventricular progenitor cells
#335MICROFLUIDIC DEVICE FOR CULTURING CELLS
#336Methods of propagating rhinovirus C in previously unsusceptible cell lines
#337ELECTRODE CONFIGURATION SCHEME FOR ELECTROPHYSIOLOGICAL TESTING DEVICES
#338Engineered renal tissues, arrays thereof, and methods of making the same
#339Fluorescent compounds as sensing agents
#340In vitro toxicity screening assay
#341Means and methods for the determination of the biological activity of BoNT/E in cells
#342Method of determining cellular protein homeostasis
#343Method for producing hepatic stem/precursor cells from mature hepatic cells using low-molecular-weight compound
#344Methods and systems for high-throughput toxicity screening of a compound using mahalanobis values
#345Cell culture
#346A renal cell line with stable transporter expression
#347Cytotoxicity test method for medical devices
#348Device and method for analyzing biological objects with Raman spectroscopy
#349Carbopyronone compounds useful as diagnostic adjuvants
#350toxin receptors and uses thereof
#351COMPOSITIONS AND METHODS FOR INCREASING HEPATOCYTE FUNCTIONAL LIFETIME IN VITRO
#352STABILIZED BIOACTIVE PEPTIDES AND METHODS OF IDENTIFICATION, SYNTHESIS, AND USE
#353NON-INVASIVE, IN VITRO FUNCTIONAL TISSUE ASSAY SYSTEMS
#354Methods for Establishing Threshold Limits for a Chemical or Biological Agent in a Target Species
#355Combination of opioids and anticancer drugs for cancer treatment
#356In vitro test system to evaluate xenobiotics as immune-modulators of drug transport and metabolism in human hepatocytes
#357Method for predicting side effect of whitening ingredient
#358Methods for the design of mechanism-based sirtuin activating compounds
#359Method for producing retinal pigment epithelial cells
#360IN VITRO GENOTOXICITY ASSAY USING A TRANSCRIPTOMIC BIOMARKER WITH DIRECT DIGITAL COUNTING
#361Method of using mouse having a humanized cluster of differentiation 47 gene
#362METHOD FOR PRODUCING RETINAL TISSUE
#363INDIVIDUAL METHOD PREDICTIVE OF THE DNA-BREAKING GENOTOXIC EFFECTS OF CHEMICAL OR BIOCHEMICAL AGENTS
#364PREDICTIVE METHOD FOR CHARACTERIZING THE SENSITIVITY OF A TUMOUR IN RESPONSE TO A DNA-BREAKING TREATMENT
#365METHOD FOR ASSISTING PREDICTION OF RISK OF OCCURRENCE OF SIDE EFFECT OF IRINOTECAN
#366GDF-15 as a haematological toxicity biomarker
#367Method of Estimating the Incidence of In Vivo Reactions to Chemical or Biological Agents Using In Vitro Experiments
#368High throughput 3D assay for immune cell and drug homing, migration and tumor cytotoxicity
#369Engineered platforms to stabilize both hepatocytes and endothelial cells in vitro
#370Method for measuring in vivo inhibition of intracellular RNase
#371Method of determining, identifying or isolating cell-penetrating peptides
#372COMPOSITIONS AND ASSAYS FOR DETERMINING CELL VIABILITY
#373IPSC-EC PERFORMANCE ENHANCEMENT VIA SIRT1 OVEREXPRESSION
#374ISOLATION OF HUMAN NEURAL STEM CELLS FROM AMNIOTIC FLUID OF PATIENTS WITH NEURAL TUBE DEFECTS
#375Biocompatible and bioabsorbable derivatized chitosan compositions
#376MULTILAYER SHEET OF CELLS
#377ENGINEERED MODEL OF FIBROTIC DISEASES
#378SYSTEMS AND METHODS FOR PREDICTING CARDIOTOXICITY OF MOLECULAR PARAMETERS OF A COMPOUND BASED ON MACHINE LEARNING ALGORITHMS
#379METHOD AND APPARATUS FOR HIGH-RESOLUTION IMAGING OF CELL-CELL COMMUNICATION
#380Methods for isolating human cardiac ventricular progenitor cells
#381HEPATOCYTES AND HEPATIC NON-PARENCHYMAL CELLS, AND METHODS FOR PREPARATION THEREOF
#382Chip platforms for microarray 3D bioprinting
#383Antibacterial polypeptide libraries and methods for screening the same
#384METHOD FOR PRODUCING ARTIFICIAL SYNCYTIOTROPHOBLAST AND PROGENITOR CELL THEREOF
#385Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomic ratios
#386High throughput BH3 profiling: a rapid and scalable technology to BH3 profile on low numbers of cells
#387COMPOSITIONS AND METHODS FOR ASSESSING TOXICITY USING DYNAMIC BH3 PROFILING
#388Component analysis device, drug component analysis device, component analysis method, and drug component analysis method
#389CRISPR/CAS GLOBAL REGULATOR SCREENING PLATFORM
#390METHODS FOR CHARACTERIZING TIME-BASED HEPATOTOXICITY
#391Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations
#392IN VITRO DRUG METABOLISM REAGENT AND USES THEREOF
#393Cell line stably expressing Nav1.5 and method of screening therapeutic agent using the cell line
#394SYSTEM AND METHOD FOR HIGH THROUGHPUT SCREENING OF CANCER CELLS
#395SYSTEMS AND METHODS OF SELECTING COMPOUNDS WITH REDUCED RISK OF CARDIOTOXICITY USING CARDIAC SODIUM ION CHANNEL MODELS
#396Blood brain barrier models and methods to generate and use the same
#397Methods of treating and preventing infections and associated conditions
#398NON-RADIOACTIVE METHOD FOR DETERMINING THE CYTOLITIC ACTIVITY OF AN AGENT WITH RESPECT TO TARGET CELLS, USE THEREOF AND ASSOCIATED KIT
#399Assays for measuring cardiotoxicity
#400Plant-derived nanofibrillar cellulose hydrogel for cell culture and chemical testing
#401Compositions and methods of cell attachment
#402Compositions and methods of cell attachment
#403Compositions and methods of cell attachment
#404Compositions and methods of cell attachment
#405Compositions and methods of cell attachment
#406Articles for diagnosis of liver fibrosis
#407Compositions and methods of cell attachment
#408FLIP - A SELECTIVE MOLECULAR TARGET OF SENESCENT CELLS
#409Humanized FcγR mice
#410One step phagocytosis-cell activation-cell death assay
#411Method of measuring cell-substrate impedance in living cells to identify compounds affecting receptor tyrosine kinase (RTK) activity and pathways
#412Amorphous, porous silicon materials and related methods
#413Methods and products for expressing proteins in cells
#414TOXICANT ASSAYS FOR COSMETIC PRODUCTS
#415Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#416Chiral library screen
#417Cellular-based method for determining the biological activity of defibrotide
#418Production method for retinal tissue
#419Production method for nerve tissue
#420TISSUE-MIMICKING HYDROGEL COMPOSITIONS FOR BIOFABRICATION
#421Bio-assessment device and method of making the device
#422Neuroprotective Chemicals and Methods for Identifying and Using Same
#423Effect-directed identification of targeted and non-targeted androgen disruptors
#424Engineering a heterogeneous tissue from pluripotent stem cells
#425AVOCADO-DERIVED LIPIDS FOR USE IN TREATING LEUKEMIA
#426Microfluidic aspirator and methods of making and using the same
#427METHODS FOR SCREENING ANTIBODIES
#428Devices for fluid management
#429Curcumin-based compositions and methods of use thereof
#430Immuno-based botulinum toxin serotype A activity assays
#431H3.3 CTL peptides and uses thereof
#432Multi-organ media compositions and methods of their use
#433Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways
#434Methods of inducing metabolic maturation of human pluripotent stem cells— derived hepatocytes
#435Differentiation of hepatocyte-like cells from stem cells
#436EVALUATION OF THE POTENTIAL RISK OF DRUG INDUCED MOOD DISTURBANCE AND SUICIDE: USE OF A DEDICATED PLATFORM
#437Immuno-based retargeted endopeptidase activity assays
#438In vitro blood-brain barrier model
#439Multi-well quartz crystal microbalance mass and viscoelastic sensor
#440Fluorescent compounds as sensing agents
#441Compositions and methods for regulating glucose homeostasis and insulin action
#442DETECTION METHOD USING RECOMBINANT LIVING CELLS FOR DETECTING XENOBIOTIC SUBSTANCES AND ARRANGEMENT AND TEST KIT FOR PERFORMING THE DETECTION METHOD
#443MINITURIZED HIGH EFFICIENCY SCREENING PROCESS FOR IDENTIFYING FUNGAL EXTRACTS WITH POTENTIAL THERAPEUTIC VALUE
#444Eluting analytes from bead arrays
#445Methods and products for expressing proteins in cells
#446Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
#447SYSTEMS AND METHODS FOR CULTURING NEPHRON PROGENITOR CELLS
#448DATA ANALYSIS OF CELLS UNDERGOING EXCITATION CONTRACTION COUPLING AS DETECTED ON REAL-TIME CELL ANALYSIS (RTCA) INSTRUMENTS
#449Oligonucleotides for inducing paternal UBE3A expression
#450Microarray compositions and methods of their use
#451Culture medium composition and method of culturing cell or tissue using thereof
#452Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
#453Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
#454Lung model device for inhalation toxicity testing
#455Colorimetric detection sensor and colorimetric detection method for detecting cyanide anion by etching of gold nanorods
#456Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
#457IN VITRO CELLULAR ANALYSIS
#458Engineered renal tissues, arrays thereof, and methods of making the same
#459Methods for immortalization of epithelial cells
#460Biocompatible and bioabsorbable derivatized chitosan compositions
#461On-chip assay for environmental surveillance
#462CELL LINE-BASED REDIRECTED T-CELL CYTOTOXICITY ASSAY
#463Methods of propagating rhinovirus C in previously unsusceptible cell lines
#464Stabilizied bioactive peptides and methods of identification, synthesis and use
#465METHOD OF DIFFERENTIATING MAMMALIAN PROGENITOR CELLS INTO INSULIN PRODUCING PANCREATIC ISLET CELLS
#466Carbopyronone compounds useful as diagnostic adjuvants
#467METHOD OF PREPARING CELLS FOR 3D TISSUE CULTURE
#468Neuroprotective chemicals and methods for identifying and using same
#469CHEMICAL THREAT ASSESSMENT BY RAPID MOLECULAR PHENOTYPING
#470Rapid method for measuring cytotoxicity in non-RI system
#471Methods and products for expressing proteins in cells
#472Predictive method of characterizing the radiosensitivity and tissular reaction of a patient to therapeutic ionizing radiation
#473Predictive method for determining tissual radiosensitivity
#474Methods of treating and preventing infections and associated conditions
#475IN VITRO ASSAYS FOR INHIBITION OF MICROGLIAL ACTIVATION
#476Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations
#477COMPOSITIONS AND METHODS FOR DETECTING AND MODULATING CELL DEATH BY A TRANSLATION REGULATED GENE EXPRESSION SYSTEM
#478SUPERANTIGEN POST-EXPOSURE THERAPY
#479Short Bio-Active Peptides for Promoting Wound Healing
#480Method for manufacturing ciliary marginal zone-like structure
#481Engineered potent cytotoxic stapled BH3 peptides
#482SYSTEMS AND METHODS FOR STUDYING INFLAMMATION-DRUG INTERACTIONS
#483SPERM-SPECIFIC CATION CHANNEL, CATSPER4, AND USES THEREFOR
#484Anuran cross-species molecular sensors
#485Basket for use with a fluidics device
#486Multiplexing transcription factor reporter protein assay process and system
#487METHOD FOR THE ISOLATION, PURIFICATION AND AMPLIFICATION OF RENAL PROGENITORS CD133+CD24+ FROM THE URINE OF PATIENTS SUFFERING FROM RENAL DISEASES
#488METHOD AND APPARATUS FOR SIGNAL TRANSDUCTION PATHWAY PROFILING
#489BICOMPATIBLE LIQUID AND METHOD FOR SCREENING SAME
#490Device and method for standardizing myoblast differentiation into myotubes
#491Isolation of human neural stem cells from amniotic fluid of patients with neural tube defects
#492Cardiotoxicity screening methods
#493METHOD FOR PREPARING HEPATOCYTE AND METHOD FOR EVALUATING DRUG HEPATOTOXICITY OF INTEREST
#494MICROSCALE MICROPATTERNED ENGINEERED IN VITRO TISSUE
#4953D ADCC NK FACS assay
#496Cells expressing apolipoprotein E and uses thereof
#497REPROGRAMMING OF PLURIPOTENT STEM CELLS FOR IMPROVED CONTROL OF THEIR DIFFERENTIATION PATHWAYS
#498Bioreactor system
#499COMPOSITIONS AND METHODS RELATED TO OAT SENSITIVITY
#500Renal progenitor cells
#501HLA class I-expressing non-human animal
#502Sensitized cultured cells for botulinum toxin characterization
#503Assay for drug discovery based on in vitro differentiated cells
#504ASSAY FOR DRUG DISCOVERY BASED ON IN VITRO DIFFERENTIATED CELLS
#505Means and methods for the determination of the biological activity of neurotoxin polypeptides in cells
#506Methods for Genetically Diversified Stimulus-Response Based Gene Association Studies
#507Derivation of human microglia from pluripotent stem cells
#508Non-human animals having a humanized cluster of differentiation 47 gene
#509Combination therapies for malaria
#510Use of LIFR or FGFR3 as a cell surface marker for isolating human cardiac ventricular progenitor cells
#511Engineered renal tissues, arrays thereof, and methods of making the same
#512COMPOSITIONS AND ASSAYS FOR DETERMINING CELL VIABILITY
#513TWO AND THREE DIMENSIONAL DECELLULARIZED ECM CONSTRUCTS AND USES THEREFOR
#514Method of deriving mature hepatocytes from human embryonic stem cells
#515METHOD AND DEVICE FOR EXAMINING MYOCARDIAL TOXICITY AND EVALUATING CARDIOMYOCYTES
#516Device and method for wetting a sample with an aerosol
#517METHODS OF DETECTING NEUROTOXIN USING SYNAPTIC ACTIVITY
#518Dynamic BH3 profiling
#519Amyloid beta expression constructs and uses therefor
#520Screening of conjugated antibodies
#521Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof
#522Low affinity FCGR deficient mice
#523Kits and methods for cyanide detection
#524CYLINDRINS AS ETIOLOGIC AGENTS OF AMYLOID DISEASES
#525Immuno-based retargeted endopeptidase activity assays
#526Devices, systems and methods for high-throughput electrophysiology
#527PREDICTING HUMAN DEVELOPMENTAL TOXICITY OF PHARMACEUTICALS USING HUMAN STEM-LIKE CELLS AND METABOLOMIC RATIOS
#528Methods for determining the effect of an agent on tissue stem cells
#529Methods for identifying candidates for the treatment of neurodegenerative diseases
#530Method and system for in vitro developmental toxicity testing
#531Method for cell differentiation
#532Methods of treating and preventing infections and associated conditions
#533Method and system for continous monitoring of toxicity
#534MICROPATTERNED CO-CULTURE SYSTEMS AS INFECTIOUS DISEASE ANALYSIS PLATFORMS
#535Label free method for assessing chemical cardiotoxicity
#536COMBINATION OF OPIOIDS AND ANTICANCER DRUGS FOR CANCER TREATMENT
#537HEPATITIS C VIRUS PARTICLES FORMATION PROMOTER, AND METHOD OF PRODUCING HEPATITIS C VIRUS PARTICLES
#538Novel Gene Targets Associated with Amyotrophic Lateral Sclerosis and Methods of Use Thereof
#539METHODS OF PREPARING PLURIPOTENT STEM CELLS
#540Methods for detecting and monitoring endocrine disrupting chemicals (EDCs)
#541COMPENDIUM OF READY-BUILT STEM CELL MODELS FOR INTERROGATION OF BIOLOGICAL RESPONSE
#542Sperm-Specific Cation Channel, Catsper3, and Uses Therefor
#543In vitro assay for predicting renal proximal tubular cell toxicity
#544SPERM-SPECIFIC CATION CHANNEL, CATSPER4, AND USES THEREFOR
#545Cholyl-L-Lysyl-Fluorescein Assay
#546Screening method, screening kit and analysis program
#547Transgenic biosensor
#548Cell culture
#549Human hepatocyte-like cells and uses thereof
#550Dynamic monitoring of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) activity and pathways in living cells using real-time microelectronic cell sensing technology
#551Methods for producing cells having a phenotype of a primary human hepatocytes and compositions
#552System and methods for identifying cancer cell lines having anti-growth activity against other cancer cell lines
#553CULTURED HEPATOCYTE AND METHOD FOR PREPARING THE SAME
#554TOXIN DETECTION USING STEM CELL DERIVED NEURONS
#555METHOD OF DETERMINING TERATOGENIC RISK
#556Neuroprotective chemicals and methods for identifying and using same
#557Encoded microcapsules and microarray fabricated therefrom
#558LIM kinasemodulating agents for neurofibromatoses therapy and methods for screening for same
#559Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignancies
#560METHOD OF SCREENING PHARMACEUTICALS FOR DRUG INTERACTIONS AND NEPHROTOXICITY
#561Anuran cross-species molecular sensors
#562Chimeric Fc-gamma receptor and method for determination of ADCC activity by using the receptor
#563BIOREACTOR SYSTEM
#564Neurofibromatoses therapeutic agents and screening for same
#565DEVICES AND METHODS FOR OBSERVING EUKARYOTIC CELLS WITHOUT CELL WALL
#566Brain-specific enhancers for cell-based therapy
#567Systemic genotoxicity as blood marker for allergic inflammation
#568MEANS AND METHODS FOR ASSESSING NEURONAL TOXICITY
#569Devices, systems and methods for high-throughput electrophysiology
#570DEVICES AND METHODS FOR DETERMINING SENSITIVITY TO RADIATION
#571MEANS AND METHODS FOR ASSESSING KIDNEY TOXICITY
#572NEURONAL BIOSENSOR FOR DETECTION OF TOXINS
#573Methods for programming differentiated cells into hematopoietic stem cells
#574Therapeutic approach for polyglutamine degeneration
#575In vitro test system to evaluate xenobiotics as immune-modulators of drug transport and metabolism in human hepatocytes
#576COMPOSITIONS AND METHODS FOR THE TREATMENT AND ANALYSIS OF NEUROLOGICAL DISORDERS
#577Predicting toxicity of a compound over a range of concentrations
#578Microarray compositions and methods of their use
#579Engineering a heterogeneous tissue from pluripotent stem cells
#580HUMAN EMULATED RESPONSE WITH MICROFLUIDIC ENHANCED SYSTEMS
#581GENOTOXICITY TESTING
#582DRUG SCREENING METHOD AND USES THEREOF
#583METHOD OF IDENTIFYING AGENTS THAT AFFECT MATURATION, SURVIVAL AND MYELINATION
#584Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#585Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#586Methods, Systems, and Compositions for In Vitro Concentric Cell Culture Analog Systems
#587Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomics
#588CELL CHIPS
#589METHODS OF MEASURING CELL VIABILITY IN TISSUE ENGINEERED PRODUCTS
#590Modulation of complement-dependent cytotoxicity through modifications of the C-terminus of antibody heavy chains
#591Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations
#592QUANTITATIVE SOFT AGAR COLONY FORMATION ASSAY USING TETRAZOLIUM THAT GENERATES WATER-SOLUBLE FORMAZAN
#593Method for selecting mevalonate synthesis modulators using cells derived from human pluripotent cells
#594Genotoxicity as a biomarker for inflammation
#595Methods and kits for measuring toxicity and oxidative stress in live cells
#596In vitro method for predicting in vivo genotoxicity of chemical compounds
#597Molecular flux rates through critical pathways measured by stable isotope labeling In Vivo, as biomarkers of drug action and disease activity
#598Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#599PREDICTIVE RENAL SAFETY BIOMARKERS AND BIOMARKER SIGNATURES TO MONITOR KIDNEY FUNCTION
#600Macrophage hazardous material detection